Our Company
Presentation
Management Team
Board of directors
Scientific Advisory Board
Contact
Products
Tedopi®
OSE-279
Lusvertikimab (OSE-127)
Pegrizeprument (FR104)
BI 770371
ABBV-230
CLEC-1
Research & Development
Scientific publications
Investors
Press Releases
Letter to Shareholders
Newsletters
Q & A
Financial documents
General Shareholders’ meetings
Regulated information
Partnerships
Pharma partnerships
Clinical partnerships
Academic and public Partnerships
News
Agenda
Press Releases
Contact
en
fr
Back to agenda
Date
19/01/2024
Place
Breckenridge, CO, USA
KEYSTONE SYMPOSIA on Molecular and Cellular Biology
January 17, 2024 - Inhibitory Immune Receptors in Cancer Development and Therapy - Nicolas Poirier, OSE Immunotherapeutics, France - Selective Anti-SIRPa Targeting in Immuno-Oncology